Based on the Virtus LifeSci Biotech Clinical Trials ETF stock forecast from 0 analysts, the average analyst target price for Virtus LifeSci Biotech Clinical Trials ETF is not available over the next 12 months. Virtus LifeSci Biotech Clinical Trials ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Virtus LifeSci Biotech Clinical Trials ETF is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Virtus LifeSci Biotech Clinical Trials ETF’s stock price was USD 26.85. Virtus LifeSci Biotech Clinical Trials ETF’s stock price has changed by +1.19% over the past week, -8.69% over the past month and +42.01% over the last year.
No recent analyst target price found for Virtus LifeSci Biotech Clinical Trials ETF
No recent average analyst rating found for Virtus LifeSci Biotech Clinical Trials ETF
Company Overview Virtus LifeSci Biotech Clinical Trials ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. Read Less
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that...Read More
Stock Target Advisor's fundamental analysis for Virtus LifeSci Biotech Clinical Trials ETF's stock is Bearish.
BBC stock's dividend yield is 0.29%.
Our analysis grades BBC stock's dividend yield at F. This means that BBC stock's dividend yield is above 38% of the stocks in the Health sector in the NYE exchange.
Based on this BBC may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on BBC's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BBC's stock to indicate if its overvalued.
The last closing price of BBC's stock was USD 26.85.
The most recent market capitalization for BBC is USD 0.01B.
Unfortunately we do not have enough analyst data on BBC's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Virtus LifeSci Biotech Clinical Trials ETF's stock.
As per our most recent records Virtus LifeSci Biotech Clinical Trials ETF has 0 Employees.
Sorry we do not have any infomation available on Virtus LifeSci Biotech Clinical Trials ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Stock Target Advisor's fundamental analysis for Virtus LifeSci Biotech Clinical Trials ETF's stock is Bearish.
BBC stock's dividend yield is 0.29%.
Our analysis grades BBC stock's dividend yield at F. This means that BBC stock's dividend yield is above 38% of the stocks in the Health sector in the NYE exchange.
Based on this BBC may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on BBC's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BBC's stock to indicate if its overvalued.
The last closing price of BBC's stock was USD 26.85.
The most recent market capitalization for BBC is USD 0.01B.
Unfortunately we do not have enough analyst data on BBC's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Virtus LifeSci Biotech Clinical Trials ETF's stock.
As per our most recent records Virtus LifeSci Biotech Clinical Trials ETF has 0 Employees.
Sorry we do not have any infomation available on Virtus LifeSci Biotech Clinical Trials ETF's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BBC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
